Tianjin TEDA Biomedical Engineering Company Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 449.68 million compared to CNY 476.38 million a year ago. Net loss was CNY 28.11 million compared to CNY 42.26 million a year ago.

Basic loss per share from continuing operations was CNY 0.0148 compared to CNY 0.0223 a year ago.